Vir Biotechnology (VIR) Net Margin Growth (1y) (2019 - 2026)

Vir Biotechnology (VIR) Net Margin Growth (1y) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,491.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,120.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -653.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 447.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Vir Biotechnology 1.38 Bn 1.38 Bn - -42.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -42.94 Mn
Dec 31, 2025 77,824.00
Sep 30, 2025 -5.90 Mn
Jun 30, 2025 -463,977.00
Mar 31, 2025 -386,335.00
Dec 31, 2024 -15,438.00
Sep 30, 2024 -278,747.00
Jun 30, 2024 62,961.00
Mar 31, 2024 9,754.00
Dec 31, 2023 -48,522.00
Sep 30, 2023 -623,904.00
Jun 30, 2023 -494,144.00
Mar 31, 2023 -26,588.00
Dec 31, 2022 -27,026.00
Sep 30, 2022 -5,977.00
Jun 30, 2022 -22,500.00
Mar 31, 2022 859,021.00
Dec 31, 2021 679,675.00
Sep 30, 2021 449,501.00
Jun 30, 2021 10,871.00